Dre Joanne Liu (@drejoanneliu.bsky.social)

Good news of the decade: Acoziborole Winthrop, developed by @dndi.org & Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose Rx for most common form of sleeping sickness-soon over injectable arsenic derivative Rx with serious side effects dndi.org/press-releas...

loading . . .

Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness The recommendation is based on Phase II/III study demonstrating up to 96% success rates at 18 months across both early and advanced stages of T.b. gambiense, the most common form of sleeping sickness. https://dndi.org/press-releases/2026/acoziborole-winthrop-developed-dndi-sanofi-receives-european-medicines-agency-positive-opinion-sleeping-sickness/?utm_source=DNDi&utm_campaign=908f92e3fe-eNews_december-2024_COPY_01&utm_medium=email&utm_term=0_4c3dd201d2-908f92e3fe-277469710